PA Flume, TM Egan, LJ Paradowski, FC Detterbeck, JT Thompson and JR Yankaskas
Department of Medicine, University of North Carolina at Chapel Hill.

It has been suggested that the presence of airway pathogens prior to lung transplantation (LT) in patients with cystic fibrosis (CF) may place these patients at a higher risk for infectious complications after LT. There is particular concern regarding patients colonized with multiresistant Pseudomonas, including P. cepacia, and fungi, including Aspergillus. We report our experience with LT for patients with CF and compare the results with those of patients with LT for other indications. Between January 1990 and March 1993, we performed LT for 27 patients with CF and 32 without CF. Nearly all (89%) of the patients with CF were colonized with P. aeruginosa; many were cultured with P. cepacia (19%) and Aspergillus (63%). The non-CF group rarely had organisms identified pre-LT. No patients with CF underwent pre-LT sinus drainage or received pre-LT treatment for Aspergillus. All of the patients received perioperative antibiotics and a standard regimen of immunosuppression and prophylactic antibiotics. The incidence of infectious complications was the same in the two groups; however, there was an association between obliterative bronchiolitis and pulmonary infections. One of the patients with CF with P. cepacia died as a result of this organism. None of the patients with CF required treatment for Aspergillus post-transplant. We conclude that patients with CF, despite the presence of airway pathogens, are at no greater risk of infectious complications after LT than are other patients.

This article has been cited by other articles:

				D. E. Griffith, T. Aksamit, B. A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, S. M. Holland, R. Horsburgh, G. Huitt, M. F. Iademarco, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 367 - 416. [Full Text] [PDF]

				W Chalermskulrat, N Sood, I P Neuringer, T M Hecker, L Chang, M P Rivera, L J Paradowski, and R M Aris Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation Thorax, June 1, 2006; 61(6): 507 - 513. [Abstract] [Full Text] [PDF]

				R.M. Kotloff and V.N. Ahya Medical complications of lung transplantation Eur. Respir. J., February 1, 2004; 23(2): 334 - 342. [Abstract] [Full Text] [PDF]

				W. Chalermskulrat, I. P. Neuringer, J. L. Schmitz, D. J. Catellier, M. J. Gurka, S. H. Randell, and R. M. Aris Human Leukocyte Antigen Mismatches Predispose to the Severity of Bronchiolitis Obliterans Syndrome After Lung Transplantation Chest, June 1, 2003; 123(6): 1825 - 1831. [Abstract] [Full Text] [PDF]

				M. Helmi, R. B. Love, D. Welter, R. D. Cornwell, and K. C. Meyer Aspergillus Infection in Lung Transplant Recipients With Cystic Fibrosis: Risk Factors and Outcomes Comparison to Other Types of Transplant Recipients Chest, March 1, 2003; 123(3): 800 - 808. [Abstract] [Full Text] [PDF]

				T.M. Egan, F.C. Detterbeck, M.R. Mill, M.S. Bleiweis, R. Aris, L. Paradowski, G. Retsch-Bogart, and B.S. Mueller Long term results of lung transplantation for cystic fibrosis Eur. J. Cardiothorac. Surg., October 1, 2002; 22(4): 602 - 609. [Abstract] [Full Text] [PDF]

				D. R. Nunley, A. A. Gal, J. D. Vega, C. Perlino, P. Smith, and E. C. Lawrence Saprophytic Fungal Infections and Complications Involving the Bronchial Anastomosis Following Human Lung Transplantation Chest, October 1, 2002; 122(4): 1185 - 1191. [Abstract] [Full Text] [PDF]

				S. Lick and A. Duarte Of Mycetomas and Men Chest, January 1, 2002; 121(1): 5 - 6. [Full Text] [PDF]

				C. CHAPARRO, J. MAURER, C. GUTIERREZ, M. KRAJDEN, C. CHAN, T. WINTON, S. KESHAVJEE, M. SCAVUZZO, E. TULLIS, M. HUTCHEON, et al. Infection with Burkholderia cepacia in Cystic Fibrosis . Outcome Following Lung Transplantation Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 43 - 48. [Abstract] [Full Text]

				B. Mehrad, G. Paciocco, F. J. Martinez, T. Clark Ojo, M. D. Iannettoni, and J. P. Lynch III Spectrum of Aspergillus Infection in Lung Transplant Recipients : Case Series and Review of the Literature Chest, January 1, 2001; 119(1): 169 - 175. [Abstract] [Full Text] [PDF]

				H. P. McAdams, J. J. Erasmus, and S. M. Palmer Complications (Excluding Hyperinflation) Involving the Native Lung after Single-Lung Transplantation: Incidence, Radiologic Features, and Clinical Importance Radiology, January 1, 2001; 218(1): 233 - 241. [Abstract] [Full Text]

				E. M. Marom, H. P. McAdams, S. M. Palmer, J. J. Erasmus, T. A. Sporn, V. F. Tapson, R. D. Davis, and P. C. Goodman Cystic Fibrosis: Usefulness of Thoracic CT in the Examination of Patients before Lung Transplantation Radiology, October 1, 1999; 213(1): 283 - 288. [Abstract] [Full Text]

				D. E. Geller, H. Kaplowitz, M. J. Light, and A. A. Colin Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: Reported Prevalence, Regional Distribution, and Patient Characteristics Chest, September 1, 1999; 116(3): 639 - 646. [Abstract] [Full Text] [PDF]

				K. Wiebe, Th. Wahlers, W. Harringer, H.v.d. Hardt, H. Fabel, and A. Haverich Lung transplantation for cystic fibrosis - a single center experience over 8 years Eur. J. Cardiothorac. Surg., August 1, 1999; 14(2): 191 - 196. [Abstract] [Full Text] [PDF]

				V. Calvo, J. M. Borro, P. Morales, A. Morcillo, R. Vicente, V. Tarrazona, and F. Paris Antifungal Prophylaxis During the Early Postoperative Period of Lung Transplantation Chest, May 1, 1999; 115(5): 1301 - 1304. [Abstract] [Full Text] [PDF]

				S. M. Arcasoy and R. M. Kotloff Lung Transplantation N. Engl. J. Med., April 8, 1999; 340(14): 1081 - 1091. [Full Text] [PDF]

				S. Steinbach, L. Sun, R.-Z. Jiang, P. Flume, P. Gilligan, T. M. Egan, and R. Goldstein Transmissibility of Pseudomonas cepacia Infection in Clinic Patients and Lung-Transplant Recipients with Cystic Fibrosis N. Engl. J. Med., October 13, 1994; 331(15): 981 - 987. [Abstract] [Full Text]